Health2 years ago
Buprenorphine misuse and diversion risk for opioid use disorder appears to be lower in Medicare Part D OEI-02-22-00160 05-16-2023
May 16, 2023 | OEI-02-22-00160 | full report Main results Nearly all Medicare Part D enrollees who received buprenorphine for the treatment of opioid use disorder...
Recent Comments